7.4300
10-1月-25 16:45:00
15 分の遅延
株式
-0.3800
-4.87%
本日の幅
7.0250 - 9.1099
ISIN
N/A
ソース
NASDAQ
OnKure Announces Encouraging Preliminary Safety, Tolerability, and Pharmacokinetic (PK) Data from its First-In-Human PIKture-01 Trial of OKI-219
10 12 2024 07:00:00 提供 Nasdaq GlobeNewswire
OnKure Announces New Date for Upcoming Investor Call
25 11 2024 17:31:00 提供 Nasdaq GlobeNewswire
OnKure to Present Clinical and Preclinical Data for OKI-219 at the 2024 San Antonio Breast Cancer Symposium
01 11 2024 17:30:00 提供 Nasdaq GlobeNewswire